Rituximab-induced serum sickness in a girl with nephrotic syndrome

[1]  K. Kasahara,et al.  Rituximab-induced serum sickness with idiopathic nephrotic syndrome in a child. , 2021, Pediatrics international : official journal of the Japan Pediatric Society.

[2]  M. Yamada,et al.  The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies , 2020, CEN Case Reports.

[3]  E. Bargagli,et al.  Effects of rituximab therapy on B cell differentiation and depletion , 2020, Clinical Rheumatology.

[4]  Yuko Kajiho,et al.  Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome , 2020, CEN Case Reports.

[5]  A. Jonville-Béra,et al.  Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study. , 2019, European journal of internal medicine.

[6]  P. Langford,et al.  Kawasaki Disease: The Role of Immune Complexes Revisited , 2019, Front. Immunol..

[7]  M. Hosoya,et al.  Serum sickness with refractory nephrotic syndrome following treatment with rituximab , 2018, CEN Case Reports.

[8]  K. Nitta,et al.  Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan , 2017, Scientific Reports.

[9]  C. Bingham,et al.  Rituximab-induced serum sickness: A systematic review. , 2015, Seminars in arthritis and rheumatism.

[10]  R. Mori,et al.  Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial , 2014, The Lancet.

[11]  H. Goto,et al.  Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura , 2009, International journal of hematology.

[12]  C. Chung.  Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. , 2008, The oncologist.

[13]  M. Scheinberg,et al.  Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia. , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[14]  M. Mannik,et al.  Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). , 2001, Arthritis and rheumatism.

[15]  N. Young,et al.  Human Serum Sickness: A Prospective Analysis of 35 Patients Treated with Equine Anti‐Thymocyte Globulin for Bone Marrow Failure , 1988, Medicine.

[16]  N. Young,et al.  A Prospective Clinical and Immunologic Analysis of Patients with Serum Sickness , 1984 .

[17]  G. Neild,et al.  Cyclosporin A inhibits acute serum sickness nephritis in rabbits. , 1983, Clinical and experimental immunology.

[18]  A. Soylu,et al.  Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome. , 2020, Turkish Journal of Pediatrics.